Response Efficacy of PD-1 and PD-L1 Inhibitors in Clinical Trials: A Systematic Review and Meta-Analysis

Overview of attention for article published in Frontiers in oncology, April 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (82nd percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news: 2 news outlets

Citations

dimensions_citation: 66 Dimensions

Readers on

mendeley: 78 Mendeley

Summary News Dimensions citations

So far, Altmetric has seen 2 news stories from 2 outlets.

New I-O targets herald a decade of drugging the undruggable

PharmaLive, 13 Jan 2023

Published: Jan 13, 2023 By Heather McKenzie BioSpace There’s a revolution unfolding in cancer therapeutics as researchers learn…

New I-O Targets Herald a Decade of Drugging the Undruggable

Biospace, 13 Jan 2023

Compugen President and CEO Anat Cohen-Dayag, Ph.D./courtesy of Compugen There’s a revolution unfolding in cancer therapeutics…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.